Precigen Reports Third Quarter 2025 Financial Results and Business Updates
PAPZIMEOS (zopapogene imadenovec-drba) received full approval by the FDA in August PAPZIMEOS launched with a broad label in the US as the first and only...

What's Your Reaction?











